Evidence map›Paper›PMID 33672170›Full record

ArticleInternational journal of environmental research and public health2021

Diversity of Oxacillinases and Sequence Types in Carbapenem-Resistant

Andrea J Grisold, Josefa Luxner, Branka Bedenić, Magda Diab-Elschahawi, Michael Berktold, Agnes Wechsler-Fördös, Gernot E Zarfel

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Synergistic Inhibition ofMicroorganisms · 2026
    Article
  2. Article
  3. Genomic Characterization of Multidrug-ResistantDiagnostics (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Analysis of carbapenem-resistantInternational journal of molecular epidemiology and genetics · 2024
    Article
  7. Carbapenem Resistance inBioMed research international · 2024
    Article
  8. Prevalence of Carbapenemases in Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2023
    Article
  9. Article
  10. Article
  11. A Variant Carbapenem Inactivation Method (CIM) forPathogens (Basel, Switzerland) · 2022
    Article
  12. Antibiotic Resistance and Genotypes of Nosocomial Strains ofAntibiotics (Basel, Switzerland) · 2021
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Andrea J GrisoldD&R Institute of Hygiene, Microbiology and Environmental Medicine, Medical University Graz, Neue Stiftingtalstrasse 6, A-8010 Graz, Austria
Josefa LuxnerD&R Institute of Hygiene, Microbiology and Environmental Medicine, Medical University Graz, Neue Stiftingtalstrasse 6, A-8010 Graz, Austria
Branka BedenićDepartment of Microbiology, University Hospital Center Zagreb, 10000 Zagreb, Croatia.
Magda Diab-ElschahawiDepartment of Infection Control and Hospital Epidemiology, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.ORCID 0000-0001-9765-9239
Michael BerktoldInstitute of Hygiene and Microbiology, Medical University Innsbruck, Schöpfstrasse 41, A-6020 Innsbruck, Austria.
Agnes Wechsler-FördösHospital Rudolfstiftung, Juchgasse 25, 1030 Wien, Austria.ORCID 0000-0002-8402-328X
Gernot E ZarfelD&R Institute of Hygiene, Microbiology and Environmental Medicine, Medical University Graz, Neue Stiftingtalstrasse 6, A-8010 Graz, AustriaORCID 0000-0003-1592-4559
Innsbruck Medical University · ATMedical University of Vienna · ATRudolfinerhaus Hospital · ATUniversity Hospital Centre Zagreb · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbapenem-resistant

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsAnti-Bacterial AgentsAustriaBacterial Proteinsbeta-LactamasesCarbapenemsHumansMicrobial Sensitivity TestsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsoxacillinaseAcinetobacter baumanniiAcinetobacter pittiiimipenemmeropenemOXA-143OXA-23OXA carbapenemases

Identifiers

PMID33672170
PMCPMC7926329
OpenAlexW3130334569

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.